AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 201 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,624 | -29.8% | 106 | -19.7% | 0.00% | – |
| Q2 2023 | $3,739 | +89.2% | 132 | +53.5% | 0.00% | – |
| Q1 2023 | $1,976 | -2.3% | 86 | +19.4% | 0.00% | – |
| Q4 2022 | $2,022 | -81.6% | 72 | -81.1% | 0.00% | -100.0% |
| Q3 2022 | $11,000 | +37.5% | 381 | +3.8% | 0.00% | 0.0% |
| Q2 2022 | $8,000 | +700.0% | 367 | +773.8% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 42 | +7.7% | 0.00% | – |
| Q4 2021 | $1,000 | -75.0% | 39 | -59.8% | 0.00% | -100.0% |
| Q3 2021 | $4,000 | -20.0% | 97 | +12.8% | 0.00% | 0.0% |
| Q2 2021 | $5,000 | +25.0% | 86 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $4,000 | 0.0% | 86 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $4,000 | +300.0% | 86 | +168.8% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 32 | +68.4% | 0.00% | – |
| Q2 2020 | $1,000 | -95.2% | 19 | -96.8% | 0.00% | -100.0% |
| Q1 2020 | $21,000 | -4.5% | 589 | +24.3% | 0.00% | +33.3% |
| Q4 2019 | $22,000 | – | 474 | +4209.1% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 11 | -90.5% | 0.00% | -100.0% |
| Q1 2019 | $7,000 | – | 116 | +625.0% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 16 | -84.0% | 0.00% | -100.0% |
| Q3 2015 | $5,000 | +400.0% | 100 | +525.0% | 0.00% | +200.0% |
| Q2 2015 | $1,000 | – | 16 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |